Wachtell, Lipton, Rosen & Katz advises boards of directors and senior executives on executive compensation issues within the context of M&A, divestitures, and complex corporate transactions. The firm handles a wide range of corporate governance challenges, including those posed by shareholder activists, proxy battles, and executive succession planning. Leading the New York-based team, Jeannemarie O’Brien is acclaimed for her executive compensation and benefits expertise in transactions involving financial services firms. Adam Shapiro and David Kahan focus on M&A, corporate governance, and executive employment agreements. Michael Schobel has a broad industry reach, with significant experience in banking, finance, technology, and pharmaceuticals, including his notable role in Pfizer’s $43 billion acquisition of Seagen; he shares this broad industry expertise with Amanda Toy. Erica Bonnett offers guidance on securities law compliance, compensation disclosures, and the structuring of executive employment contracts.
Legal 500 Editorial commentary
Key clients
- Pfizer
- FIS
- Arconic Corporation
- National Instruments
- Stone Point Capital, Warburg Pincus, Reverence Capital Partners, Sixth Street and Bayview Asset Management
- Capri Holdings
- American International Group
- CIGNA
- MDU Resources Group
- Prologis
- Adobe
- PDC Energy
- Sealed Air
- Nasdaq
- CAA
- Maxar Technologies
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Amanda Toy
Wachtell, Lipton, Rosen & KatzNext Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Michael Schobel
Wachtell, Lipton, Rosen & KatzPractice head
The lawyer(s) leading their teams.
Jeannemarie O’Brien